News

Qualitek Labs Limited will seek board approval for a fundraising exercise on September 22, 2026, which may include the issuance of equity shares or other equity-linked instruments via a rights issue, preferential allotment, or private placement, among other methods, according to a regulatory filing with the BSE Limited on September 17, 2026. The company’s trading window will be closed for directors, promoters, and designated persons from September 17, 2026, until September 24, 2026.

Qualitek Labs Limited’s board of directors approved the draft notice for the company’s 8th Annual General Meeting (AGM) to be held on September 25, 2026, in New Delhi, and recommended the re-appointment of Mr. Antaryami Nayak as Managing Director and CEO, who retires by rotation. The board also approved the re-appointment of M/s J Madan & Associates as the company’s Tax Auditor for the financial year 2026–27 and proposed an increase in the overall managerial remuneration limits from 28% to 35% of net profits, subject to member approval at the AGM.

Qualitek Labs has revised the meeting of the Board of Directors which was scheduled to be held on 15 May 2026. The meeting will now be held on 20 May 2026.

Qualitek Labs will hold a meeting of the Board of Directors of the Company on 15 May 2026.

Qualitek Labs will hold a meeting of the Board of Directors of the Company on 20 December 2025.Powered by Capital Market - Live News